New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer July 7, 2015December 14, 2022 Matthew Tontonoz
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer July 20, 2015December 14, 2022 Matthew Tontonoz
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
Oncogene Initiates Cancer Development through Immune Checkpoints March 10, 2016December 14, 2022 Alexandra Mulvey
#AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity April 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Nivolumab (Opdivo) for Advanced Hodgkin Lymphoma Patients May 17, 2016December 14, 2022 Arthur N. Brodsky, PhD